??Thank you to everyone who visited us at AACR 2024!?Special thanks to Phio Pharmaceuticals, Providence Cancer Institute, and EACRI for your invaluable collaboration. And to the patients: your courage inspires us every day. Together, let's keep making strides in the fight against cancer. In case you missed it, here's our poster: https://lnkd.in/gdywqMxr #PhioPharmaceuticals #AACR2024 #FINISHCANCER
AgonOx, Inc.
生物技术
Portland，Oregon 797 位关注者
DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER.
关于我们
AgonOx, Inc. develops novel therapies to treat cancer patients. The research strategy at AgonOx focuses on the interaction between T cells and tumor cells. Using bioinformatics, in-vitro, and in-vivo testing to identify and validate new therapeutic approaches. AgonOx conducts its research in laboratories at the Portland Providence Cancer Center where staff scientists work closely with oncologists, surgeons, and immunologists. This collaboration has led to two first-in-human clinical trials with the latest commencing in August 2023. The company’s focus in recent years has been utilizing selected tumor-reactive T cells in adoptive cell therapy for the treatment of patients with solid malignancies.
- 网站
-
https://agonox.com
AgonOx, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Portland，Oregon
- 类型
- 私人持股
- 创立
- 2012
- 领域
- Cancer immunotherapy、Immunology、Drug discovery、Oncology、Cancer research、T cell based immunotherapy、Combination treatments和Immune phenotyping
地点
-
获取路线
4805 NE Glisan St
US，Oregon，Portland，97213